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Background: The central nervous system has a complex structural organization and consists of different
subdomains along the antero-posterior axis. However, questions remain about the molecular mechanisms leading
to the regionalization of this organ. We used a previously developed methodology to identify the novel patterning
role of GDF11, a TGF-β signaling factor.
Findings: Using an assay based on neural differentiated mouse embryonic stem cells, GDF11 is shown to induce
diencephalic (posterior forebrain), mesencephalic (midbrain) and metencephalic (anterior hindbrain) fates at the
expense of telencephalic (anterior forebrain) specification. GDF11 has not previously been implicated in the early
patterning of the nervous system. In addition, inhibition of the TGF-β type I receptors Alk4, Alk5 and Alk7 by the
pharmacological inhibitor SB431542 caused a strong anteriorization of the cells.
Conclusions: Our findings suggest that GDF11 is involved in the earliest steps of the brain patterning during
neurogenesis in the vertebrate embryo and is shown to be a regionalizing factor of the regional fate in the
developing brain. This regionalization is not a typical posteriorizing signal as seen with retinoic acid, FGF or BMP
molecules. To our knowledge, this is the first time that GDF11 is implicated in the earliest steps of the patterning of
the neural plate.
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Neural development is comprised of various processes
that generate and form the nervous system during the earli-
est stages of embryogenesis. During early vertebrate devel-
opment, the central nervous system (CNS) is subdivided
along the antero-posterior (A/P) axis into forebrain, mid-
brain, hindbrain and spinal cord. Classical experiments in
Amphibia suggest the existence of a two-step mechanism
for this early organization. The neurectodermal tissue that
is formed during the process of neural induction is initially
anterior in character. It becomes secondarily posteriorized
by a series of posteriorizing, or ‘transforming’ factors to ob-
tain the full range of regional subtypes of the CNS along
the A/P axis [1-3]. Several posteriorizing factors have been* Correspondence: lleyns@vub.ac.be
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[4-8]. Nevertheless, how the regionalization of the neural
plate occurs in early mouse embryogenesis remains elusive.
An important tool to study embryonic development is
mouse embryonic stem cells (mESc). mESc are derived
from the inner cell mass (ICM) of a pre-implantation
blastocyst stage embryo and have the capacity to self-renew
unlimitedly in vitro in an undifferentiated state. Further-
more, they can be differentiated in vitro and in vivo into all
cell types of the adult body [9,10]. The parallelism between
the differentiating embryo and the in vitro differentiation of
mESc makes them an important tool to study embryonic
development.
In a previous study [11], we developed a methodology to
study mammalian early neural patterning which is based
on the neural differentiation method of mESc as described
by Ying and colleagues [12]. It involves the neural differ-
entiation of mESc in the specialized serum-free N2B27
medium system in adherent cultures to obtain neuralCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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treated with potential posteriorizing factors [11,12]. How-
ever, because many of the putative patterning factors (e.g.
Bmp4, Wnt3a) were inhibitory to neural induction and
some even had an effect on mESc self-renewal [13-18], we
designed an experimental set-up that separated the neural
induction from the neural patterning step, in order to
avoid these negative effects on neural differentiation.
The signalling by the Transforming Growth Factor β
(TGF-β) superfamily signalling is essential during a di-
verse set of cellular processes, including differentiation,
patterning, proliferation, specification of developmental
fate during embryogenesis as well as in mature tissue
[19-21]. Members of the TGF-β superfamily include acti-
vins, inhibins, Bone Morphogenic Proteins (BMPs) and
Growth of Differentiation Factors (GDFs). TGF-β factors
initiate signalling by binding a heterodimeric complex of
serine/threonine kinase transmembrane receptors, type I
and type II [19-21]. The ligand first binds to the extracel-
lular domain and activates a type II receptor homodimer,
resulting in phosphorylation of a type I receptor homodi-
mer. Once activated, the type I receptor directly phosphory-
lates and activates downstream a set of Smad proteins and
initiates the intracellular signalling cascade. Type II recep-
tors include BMPRII, ActRIIA, ActRIIB and T-β-RII. Type
I receptors include seven members, activin-like kinases
(ALK 1–7) [20,22]. There are eight distinct Smad proteins:
the receptor-regulated Smads, which include Smad1, 2, 3, 5
and 8; the Co-mediator Smad, Smad4 and the inhibitory
Smads, which include Smad6 and 7 [19].
One of the members of the TGF-β superfamily, Growth
of Differentiation Factor 11 (GDF11), also known as BMP11,
has been shown to regulate anterior-posterior patterning
of the body axis, kidney development and closure of the
palate [23-27].
In the animal cap assay (AC) in Xenopus, GDF11 in-
duces axial mesoderm and at higher concentrations also
neural tissue, an activity that can be inhibited by Follistatin
(Fst), indicating that in the AC assay, GDF11 has an effect
similar to that of Activin [25]. In the mouse, GDF11 has
been implicated in the establishment of the skeletal pattern.
Mice that are mutant for this gene die within 24 hours after
birth. They show homeotic anterior transformations of the
vertebrae, mainly in the lumbar and the thoracic regions
and a posterior displacement of the hindlimbs [27]. GDF11
regulates the patterning of the vertebrae by controlling the
expression of the Hox genes, as the expression domain of
several Hox genes is shifted in the mutants. In the chicken,
it was shown that GDF11 not only causes a shift in the ex-
pression of Hox genes, but also causes a rostral shift in the
position of the motor neuron columns and pools [28].
However, in the mouse embryo, it is not clear whether
GDF11 has a patterning effect on other tissues than skeletal
ones. In the mouse embryo, GDF11 is expressed first faintlyin the posterior half of the 7.5 dpc embryo where expres-
sion is observed in the primitive streak in the ingressing
cells forming the mesoderm. At about 8.5 dpc, GDF11 is
expressed posteriorly; in the most anterior regions of the
neural epithelium, and in both the neural epithelium and
the mesoderm in more posterior regions. At 9.0 dpc,
GDF11 continues to be expressed in the former primitive
streak region, and by 9.5 dpc, the expression is restricted
mainly to the tail bud, but is also found in the posterior
dorsal neural tube [27,29]. It was reported that GDF11
mRNA can also be detected in the encephalic region of 9.5
dpc and 10.5 dpc embryos [30]. These findings are consist-
ent with a more general role of GDF11 during neural differ-
entiation and expression in diverse neural tissues, which
include developing spinal cord, dorsal root ganglia and em-
bryonic and postnatal brain.
Based on this expression data and its skeletal patterning
role, we hypothesized that GDF11 was a potential pattern-
ing factor that could be involved in the early neural A/P
patterning of the mouse embryo. Therefore, in this study,
we investigated whether GDF11 has a direct role in the
early regional identity of neural progenitor cells and
whether this factor can posteriorize freshly induced neural
progenitors that are initially anterior in character. The po-
tential neural patterning effect of GDF11 was assessed in
our ES cell based patterning system. Our data suggest
GDF11 is an encephalic regionalizing factor during early
neural patterning in the vertebrate embryo.
Research methods
Mouse ESC cultures and differentiation
Mouse E14Tg2a feeder free ES cells were cultured in Knock
Out DMEM (Gibco, Carlsbad, CA) supplemented with
10% fetal calf serum (Hyclone, Logan, UT), 0.1 mM β-
mercaptoethanol (GIBCO), 1% non-essential amino acids
(GIBCO), 2 mM L-glutamine (Sigma, St. Louis, MO), anti-
biotics (Sigma) and 1000 U/ml LIF (Sigma), on dishes
coated with 0.1% gelatin.
For the patterning experiments, cells were cultured for
48 hours in N2B27 as described by Ying et al. [18] at a dens-
ity of 7500 cells per cm2. Subsequently, the medium was re-
placed with N2B27 containing human recombinant GDF11
(R&D systems, Minneapolis, MN) and the TGF-β type I re-
ceptor inhibitor SB-431542 (Sigma). Culture occurred for
another 4 days, refreshing the medium every 2 days.
To confirm the activity of the tested growth factors, cells
were cultured similarly for 48 hours and collected 3 hours
after treatment with the specific factor, and expression
levels of known target genes were assessed. Three inde-
pendent experiments were performed.
Quantitative reverse transcription (qRT-PCR)
RNA was extracted from the collected cell samples using
the SV Total RNA Isolation System kit (Promega, Madison,
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8.     10 ng/ml GDF11
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Figure 1 (See legend on next page.)
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Figure 1 Effect of SB431542 (SB), and GDF11 on neural patterning. The effect of different concentrations of SB, and GDF11 on the
expression level of different regional markers was assessed by qRT-PCR. The markers used were Bf1 (telencephalon) (A), Pax6 (diencephalon) (B),
Otx1 (prosencephalon and mesencephalon) (C), En1 (mesen- and metencephalon) (D), Gbx2 (metencephalon) (E), Krox20 (myelencephalon) (F)
and Hoxc9 (spinal cord) (G). The results presented here are the means of three independent experiments with the standard error of the mean.
Statistically significant changes in expression level (p < 0.05) are marked with an asterisk in the graphs, as compared to “control” (sample 6).
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of Willems et al. [31].
Primer sequences for all markers used are available in
the Real-Time Primer Database (http://medgen.ugent.
be/rtprimerdb/). Expression levels were calculated as de-
scribed using Actb as a reference gene [31]. In addition,
expression levels of all regional marker genes were di-
vided by the expression level of the panneural marker
Nestin to correct for possible effects on neural differenti-
ation [11].
Normalized expression levels of the treated samples
were then calculated relatively to the expression levels of
the corresponding untreated control, which was put at
level one. The results are presented as the means of
three independent experiments with the standard error
of the mean. Statistical analysis was performed using a
non-parametric test for comparing two groups (Mann
Whitney). Statistically significant changes (p < 0.05) are
marked with an asterisk in the graphs, as compared to
control (sample 6).
Findings
We developed a system to study early neural patterning
and showed that Fgf2, Wnt3a and Bmp4 have a strong pos-
teriorizing effect on neural differentiated mESc, similar to
what was also described to be the case in Xenopus [1,2,11].
Analyses of the patterning potential of GDF11 showed
that the addition of this factor induces a strong decrease
of the anteriormost marker Bf1, and a significant upreg-
ulation of the intermediate markers Otx1, En1 and Gbx2
(Figure 1, panel A,C-E). On the posteriormost markers
Krox20 and Hoxc9, no effect was seen (Figure 1, panel
F-G). The effect on the diencephalic marker Pax6 was
not unambiguous since at the lowest concentration
tested, an increase was observed, while at the highest
concentration tested, a decrease of Pax6 expression was
induced (Figure 1, panel B). Next, Pax6 is expressed in
neuroprogenitors in the developing spinal cord and not an
exclusively in the diencephalon. This may contribute to the
ambiguous results.
Treatment of the cells with SB431542 on the other hand,
caused a significant upregulation of anterior markers like
Bf1 and Otx1, while at most of the concentrations tested, a
downregulation of Hoxc9 expression could be observed
(Figure 1, panel A, C and G). This anteriorization indicates
that endogenous posteriorization factors are actively signal-
ling through the receptors blocked by SB431542.GDF11 could indeed contribute to the endogenous
patterning of the cells that could be inhibited by
SB431542, since its expression, as well as the expression
of the Alk4 and Alk5 type I receptors could be detected
in the control cultures by qRT-PCR (data not shown).
In all gene expression data tested above, the expres-
sion levels of all regional markers (see Figure 2 for sche-
matic diagram) were put relative to the expression level
of the panneural marker Nestin in order to correct for
possible inhibitory effects of the patterning factors tested
on neural induction. Though in our experimental set-up,
the neural induction process was separated in time from
the neural patterning process, an inhibitory effect on
Nestin expression could be seen by GDF11 treatment.
Flow cytometric analysis was used to assess the percentage
of Nestin-positive cells after treatment with these factors.
Treatment of the cells with the highest concentrations of
GDF11 reduced the number of Nestin-positive cells by
20% respectively. This indicates that in our experimental
set up the inhibitory effect of GDF11 is limited, but could
not completely be avoided. Therefore we corrected all ex-
pression data for the expression level of Nestin. These data
indicate that GDF11 exerts a fundamental role during
neural development.
Discussion
Though a neural patterning role is well established for
Activin in Xenopus and in Zebrafish [33,34], we did not
detect any posteriorizing effect by recombinant Activin A
in our mES cell based patterning system (data not shown).
Nodal, well known for its crucial role in the establishment
of the A/P body axis, was the next candidate we tested.
More precisely, the Nodal antagonists Lefty1 and Cer-
berus-like that are expressed in the anterior visceral endo-
derm (AVE) of the mouse embryo, are essential for the
anterior neural specification [35,36]. Whether Nodal itself
can posteriorize the neural tissue in the mouse has not
directly been shown and addition of recombinant Nodal
to the neural precursor cells in our system did not directly
induce any posteriorization either (data not shown).
Since SB431542 was tested and shown to affect A/P pat-
terning of the brain, we searched for other candidates like
Nodal or Activin that could signal via the Alk systems
blocked by SB431542.
Several GDFs (GDF1, GDF3, GDF8, GDF9 and GDF11)
were shown to signal through the Alk4, Alk5 or the Alk7 re-





Figure 2 Schematic diagram of the probable effect of GDF11 on the marker genes used and their respective expression patterns.
Anterior is towards the top (adapted from Reichert H, 2002 [32]). Expression domains are colour coded: the expression domain of Bf1 is shown in
the colour light blue, Otx1 domain in purple, Pax6 domain in orange, En1 domain in green, Gbx2 domain in red, Krox20 domain in dark blue and
Hoxc9 in yellow, respectively.
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establishment of the skeletal pattern [22,27]. Whether this
factor also has an effect on the regionalization of the
mouse neural tube remained elusive. In chick however,
overexpression of GDF11 in the neural tube caused a ros-
tral displacement of the Hox expression domains and the
motor neuron columns [28]. During the present study, we
investigated whether GDF11 has a direct role in the early
regional identity of neural progenitor cells and whether
this factor can posteriorize freshly induced neural progeni-
tors that are initially anterior in character. The potential
neural patterning effect of GDF11 was assessed in our ES
cell based patterning system.
GDF11 was indeed shown to be a strong patterning fac-
tor, reducing the expression levels of the most anterior
markers Bf1 (ventral telencephalon) and upregulating the
expression of more posterior neural markers like En1 (isth-
mus, midbrain to midbrain-hindbrain junction) and Gbx2
(hindbrain). The most posterior marker, Hoxc9 (neural
tube), tested remained unaffected, indicating that the role
of GDF11 is limited to the developing brain. More specific-
ally, GDF11 induces midbrain and anterior hindbrain fates
at the expense of telencephalic fates. This is the first time
that this factor is implicated in the regionalization of the
brain during early mouse development, where GDF11could play a more permissive or maintenance role for the
expansion of certain progenitors (i.e. Otx1+, En1+ progen-
itors). Furthermore, the presence of GDF11, Alk4 and
Alk5 mRNAs in the differentiated ES cells indicates that
GDF11 may be endogenously signalling in our system.
However, the observed effect for GDF11 was not com-
pletely opposite to the one observed by adding SB431542,
for example both GDF11 and SB431542 caused a signifi-
cant upregulation of anterior marker Otx1 (forebrain, but
not most rostral part, and midbrain), as compared to the
opposite effect observed on Bf1. SB431542 might exert a
pleiotophic effect, inhibiting Alk4, Alk5 as well as Alk7
[41,42]. This suggests that other TGF-β factors signalling
through these receptors (including other GDFs), may have
an additional patterning function in the developing neural
tube and that SB431542 inhibits all of these effects. This
still needs further investigation.
Because of this clear regionalizing effect of GDF11, we
also tested Follistatin, a GDF11 antagonist, for its pattern-
ing potential, but no significant changes in the expression
levels of the regional markers could be observed (data not
shown). It might be possible that, blocking receptors by
pharmalogical inhibitors, such as SB431542, is more effi-
cient than the addition of proteins antagonizing the signal-
ling factor because of the long experimental culture period.
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of the neural tube and encephalic region is established,
GDF11 was predominantly expressed in the posterior
spinal cord. This expression pattern was not fully com-
patible with the observed encephalic regionalization ef-
fect, since this was restricted anteriorly to the level of
the hindbrain. However, GDF11 expression was also de-
tected in the brain region by using the radioactive in
situ hybridization technique [30]. Our results suggest a
localized activity of GDF11 in the metencephalic region
of the brain but how this regional activity in the poster-
ior encephalic region of GDF11 is established, remains un-
clear. Future research is needed to determine if GDF11 is
acting together with another signalling molecule, possibly
another member of the TGF-β superfamily or if localized,
possibly graded, GDF11 signalling inhibitors are involved
in the patterning effect observed. Finally, it should be
noted that the regionalization by GDF11 is not a typical
posteriorizing signal as seen with retinoic acid, FGF or
BMP molecules since these also lead to an increase of
more posterior markers while GDF11 is an encephalic re-
gionalizing factor.
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